
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis is a medical device company with a strong focus on robotic technologies for use in interventional procedures. Despite lower-than-expected revenue in the first quarter, the company is working to address headwinds and remains confident in its goal to reach production of 500 magnetic catheters per month by year-end. The company also has a strong sales pipeline and expects to see revenue growth in the back-half of the year, leading to a positive outlook for the stock.
Bears say
Stereotaxis is facing several headwinds, including slow adoption of new technologies by health care providers, potential collaboration risks with other manufacturers, and long sales and installation cycles that may cause fluctuations in quarterly results. In addition, the company may face operational and cash flow challenges, as well as potential delays or limitations in hospital purchases of their robotic systems. Despite these challenges, Stereotaxis has recently achieved several regulatory approvals and is making progress on increasing their production capacity, which could drive future revenue growth. However, we remain cautious on the company's near-term outlook and reiterate a negative view on the stock.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares